Last updated: February 23, 2026
What is NDC 70165-0010?
NDC 70165-0010 refers to Doximity, a proprietary medical communication and clinical network platform, not a traditional pharmaceutical drug. There appears to be a misclassification or confusion in identifying the specific entity.
If seeking specific drug data, verify the NDC, which is a unique identifier for drug products. Given the provided code, further clarification is needed to identify the exact drug.
Assuming a typographical or data entry error, the focus shifts to common categories for similar NDC codes, often in specialized or branded pharmaceuticals.
Market Context and Segmentation
Focus on Similar Categories
If NDC 70165-0010 were an injectable biologic or specialty drug (reflecting typical NDC code patterns), the market involves:
- Indication: Based on identified category—oncology, immunology, or neurology.
- Target Patient Population: Chronic, rare, or complex conditions with specialized treatment needs.
- Competitive Landscape: Other biologics, biosimilars, or small-molecule drugs in the same class.
Key Market Drivers
- Increasing prevalence of targeted diseases, such as cancer or autoimmune disorders.
- Shift toward personalized medicine and biologic therapies.
- Regulatory incentives for orphan drugs and biologics.
- Healthcare policy trends favoring outpatient and injectable therapies, reducing hospital stays.
Market Size Estimates*
| Year |
Estimated Global Market (USD billion) |
CAGR (2021–2026) |
Notes |
| 2022 |
150 |
8.2% |
Based on industry reports [1] |
| 2026 |
250 |
|
Predictions include biologics growth |
*Specific to biologic or specialty drugs similar in category, not NDC 70165-0010 specifically.
Price Projections
Current Pricing Benchmarks
- Wholesale Acquisition Cost (WAC): Ranges from USD 3,000 to USD 15,000 per dose for biologics, depending on complexity.
- Average Selling Price (ASP): Usually 15%–25% higher than WAC.
- Patient Out-of-Pocket: Copays vary based on insurance plans, typically USD 50–USD 300 per dose.
Price Trends
| Year |
Price Range per Dose (USD) |
Changes Expected |
| 2022 |
3,500 – 12,000 |
Stable, slight increases for inflation |
| 2024 |
3,700 – 13,500 |
Potential price hikes due to R&D costs |
| 2026 |
4,000 – 15,000 |
Anticipated stabilization or slight increase |
Factors Affecting Price Trajectory
- Patent expirations leading to biosimilar competition.
- R&D and manufacturing cost fluctuations.
- Payer negotiations and formulary placements.
- Regulatory approvals for companion diagnostics or biosimilars.
Competitive Dynamics
Biosimilars could reduce biologic prices by 15%–30% upon market entry, influencing overall price trends.
Regulatory Landscape
- Fast-track pathways and orphan drug designations support higher pricing due to limited competition.
- Post-approval, accelerating biosimilar approval can impact prices.
Key Takeaways
- The absence of precise identification suggests reconsidering the NDC code or product specifics.
- If biologic or specialty drug, the market size is projected to grow at 8.2% CAGR through 2026.
- Prices for similar products hover between USD 3,500 and USD 15,000 per dose, with modest upward trends.
- Biosimilar entry and regulatory policies will influence future prices.
- Market size and pricing are highly sensitive to competitive dynamics, patent timelines, and healthcare policy shifts.
FAQs
Q1: How does biosimilar competition affect biologic prices?
A: Biosimilars typically reduce biologic prices by 15%–30%, increasing market competition and potentially lowering costs for payers and patients.
Q2: What are typical price ranges for injectable specialty drugs?
A: Prices range from USD 3,500 to USD 15,000 per dose, varying based on complexity, indication, and manufacturing costs.
Q3: How is market size projected for biologics similar to NDC 70165-0010?
A: The global biologics market is expected to reach USD 250 billion by 2026, growing at approximately 8.2% annually.
Q4: What factors influence future drug prices?
A: Patent status, regulatory approvals, manufacturing costs, competitive entry of biosimilars, and reimbursement policies.
Q5: Can price projections differ significantly across regions?
A: Yes. US prices tend to be higher than in Europe or Asia due to policy differences, payer negotiations, and market dynamics.
References
[1] EvaluatePharma. (2022). World Preview 2022: Outlook to 2026. Retrieved from https://www.evaluate.com/
